Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation +/- Taxotere (Docetaxel) for Non-metastatic Prostate Cancer Patients With a Rising PSA

NCT03119857 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT03119857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03119857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation +/- Taxotere (Docetaxel) for Non-metastatic Prostate Cancer Patients With a Rising PSA
Lead sponsor
Göteborg University
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2009
Completion date
April 30, 2023
Enrollment
349 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms